See All Slides - tctmd.com

Slides

Presentation TCT 2012

Design of a Fully Drug-Eluting Bioabsorbable Scaffold with EPC-Capture Technology

Presenter: Robert Cottone

October 23, 2012

Presentation TCT 2012

Antithrombotic Strategies in Patients on Chronic Oral Anticoagulation

Presenter: Ramon Quesada

October 23, 2012

Presentation TCT 2012

TCT-91. Peri-valvular Aortic Regurgitation in Balloon-expendable and Self-expendable TAVI procedures: Predictors and Impact on Clinical Outcome - Insights from the FRANCE2 Registry

Presenter: Eric van Belle

October 23, 2012

Presentation TCT 2012

Respicardia

Presenter: Robin Germany

October 23, 2012

Presentation TCT 2012

Orsiro (BIOTRONIK) Program Update

Presenter: Stephan Windecker

October 23, 2012

Presentation TCT 2012

Atrial Fibrillation:
1. CHADS2 vs. CHA2DS2-VASc Risk Assessment.
2. AHA/ACC vs. ACCP/ESC Approach to Stroke Prevention.

Presenter: Peter Brady

October 23, 2012

Presentation TCT 2012

Case 3: During an Iliofemoral Intervention

Presenter: D. Christopher Metzger

October 23, 2012

Presentation TCT 2012

Overview 2: Biological Therapies for Heart Failure: Regulatory Perspectives

Presenter: Steve Winitsky

October 23, 2012

Presentation TCT 2012

TCT-61. Infarct Size-Determined Uptake of CD34+ Cells in the Peri-Infarct Zone and Left Ventricular Remodeling: Insights from Integration of Labeled Cells Uptake SPECT...

Presenter: Piotr Musialek

October 23, 2012

Presentation TCT 2012

CorAssist

Presenter: Mitchell Krucoff

October 23, 2012

Advertisement

Slides

Design of a Fully Drug-Eluting Bioabsorbable Scaffold with EPC-Capture Technology

Antithrombotic Strategies in Patients on Chronic Oral Anticoagulation

TCT-91. Peri-valvular Aortic Regurgitation in Balloon-expendable and Self-expendable TAVI procedures: Predictors and Impact on Clinical Outcome - Insights from the FRANCE2 Registry

Respicardia

Orsiro (BIOTRONIK) Program Update

Atrial Fibrillation:
1. CHADS2 vs. CHA2DS2-VASc Risk Assessment.
2. AHA/ACC vs. ACCP/ESC Approach to Stroke Prevention.

Case 3: During an Iliofemoral Intervention

Overview 2: Biological Therapies for Heart Failure: Regulatory Perspectives

TCT-61. Infarct Size-Determined Uptake of CD34+ Cells in the Peri-Infarct Zone and Left Ventricular Remodeling: Insights from Integration of Labeled Cells Uptake SPECT...

CorAssist

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content